Large gap with delayed quotes
|
Last quote
03/10/2026
-
01:00:00
|
Bid
03/09/2026 -
20:59:59
|
Bid Volume |
Ask
03/09/2026 -
20:59:59
|
Ask Volume |
|---|---|---|---|---|
|
54.87
+0.98
(
+1.82% )
|
54.86
|
1,400 |
54.87
|
3,100 |
Analysis date: 06.03.2026
Global Evaluation
Slightly negative
Slightly negative
The stock is classified in the slightly negative zone since 06.03.2026.
Interest
None
None
No stars since 24.02.2026.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 24.02.2026 at a price of 57.60.
Evaluation
Overvalued
Overvalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately overvalued.
MT Tech Trend
Negative
Negative
The dividend-adjusted forty day technical trend is negative since 13.02.2026.
4wk Rel Perf
-16.42%
-16.42%
The four-week dividend-adjusted underperformance versus SP500 is 16.42%.
Sensibility
High
High
The stock has been on the high-sensitivity level since 06.03.2026.
Bear Market Factor
High
High
On average, the stock has a tendency to amplify the drops in the index by 1.08%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 3.28%.
Mkt Cap in $bn
8.74
8.74
With a market capitalization >$8bn, BIO-TECHNE is considered a large-cap stock.
G/PE Ratio
0.77
0.77
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
22.08
22.08
The estimated PE is for the year 2028.
LT Growth
16.40%
16.40%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
12
12
Over the last seven weeks, an average of 12 analysts provided earnings per share estimates.
Dividend Yield
0.59%
0.59%
The twelve month estimated dividend yield represents 13.11% of earnings forecasts.
Beta
109
109
For 1% of index variation, the stock varies on average by 1.09%.
Correlation
0.49
0.49
48.80% of stock movements are explained by index variations.
Value at Risk
12.94
12.94
The value at risk is estimated at USD 12.94. The risk is therefore 24.01%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
31.03.2004
31.03.2004